Predictive biomarkers for treatment with amivantamab plus lazertinib among EGFR-mu-tated NSCLC in the post-osimertinib setting: Analysis of tissue IHC and ctDNA NGSBenjamin Besse,Christina S. Baik,Melina Elpi Marmarelis,Joshua K. Sabari,Koichi Goto,Catherine A. Shu,Jong-Seok Lee,Sai-Hong Ignatius Ou,Byoung Chul Cho,Saiama Naheed Waqar,Aurelie Swalduz,Pascale Tomasini,Joshua Michael Bauml,Joshua C. Curtin, Songbai Wang, Tim Jatkoe,Michael Gormley, Leonardo Trani,Roland Elmar Knoblauch,Enriqueta FelipJOURNAL OF CLINICAL ONCOLOGY（2023）引用 0|浏览17暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
